Results 121 to 130 of about 7,447 (148)

[Research progress on toxic shock syndrome due to group A <i>Streptococcus</i> infection in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang HY, Zhou W, Huang LS.
europepmc   +1 more source

["Chongqing experiences" in treatment of bone infections]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Xie Z.
europepmc   +1 more source

[Bacterial Infection Spectrum and Antimicrobial Resistance in 2850 Cases of Community-Acquired Pneumonia in Children]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhong M, Xie J, Wang H, Fan J, Li M, Zou F, Li L.   +6 more
europepmc   +1 more source

[Role and Mechanism of Hyaluronic Acid-modified Milk Exosomes 
in Reversing Pemetrexed Resistance in Lung Adenocarcinoma Cells]. [PDF]

Zhongguo Fei Ai Za Zhi
Wu L, Lei J, Li H.
europepmc   +1 more source

配套养殖体系中部分抗生素的污染特征 [PDF]

, 2015
应光国, 杨基峰, 苏浩昌, 赵建亮, 陶然   +4 more
core  

[A case report of retroperitoneal infantile fibrosarcoma with <i>RBPMS-NTRK3</i> fusion gene positivity]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Zhou XY, Jiang J, Wang LZ, Guo JH.
europepmc   +1 more source

[Integrative Analysis of Multi-source Public Databases to Screen Core Genes 
for Constructing A Prognostic Risk Model in Lung Adenocarcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Wang C, Zhang L, Zhang Y, Wang Y, Wang M.   +4 more
europepmc   +1 more source

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xuan L, Huang H, Xu LP, Fu YW, Chen F, Wang Y, Wang SQ, Dong L, Wu JY, Wu DP.   +9 more
europepmc   +1 more source

[Molecular Epidemiology and Fluconazole Resistance Mechanisms in <i>Candida tropicalis</i> Isolates From Bloodstream Infections in Sichuan, China]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Chen W, Hou J, Peng L, Kang M, Ma Y.
europepmc   +1 more source

[Recent advances in antibody-drug conjugates for metastatic castration-resistant prostate cancer]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Xu J, Ma Y, Hu P, Yao J, Chen H, Ma Q.
europepmc   +1 more source